Kenneth Roth

Kenneth Roth

Eli Lilly and Company - Indianapolis / United States
Natural Sciences / Chemical Sciences
AD Scientific Index ID: 4458482
-
person_outline Kenneth Roth's MOST POPULAR ARTICLES
1-) Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential …B Tan, DA Young, ZH Lu, T Wang, TI Meier, RL Shepard, K Roth, Y Zhai, ...Journal of Biological Chemistry 288 (5), 3500-3511, 20131752013
2-) The folate pathway inhibitor pemetrexed pleiotropically enhances effects of cancer immunotherapyDA Schaer, S Geeganage, N Amaladas, ZH Lu, ER Rasmussen, A Sonyi, ...Clinical Cancer Research 25 (23), 7175-7188, 2019712019
3-) Effects of tirzepatide, a dual GIP and GLP-1 RA, on lipid and metabolite profiles in subjects with type 2 diabetesV Pirro, KD Roth, Y Lin, JA Willency, PL Milligan, JM Wilson, G Ruotolo, ...The Journal of Clinical Endocrinology & Metabolism 107 (2), 363-378, 2022502022
4-) Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, leads to altered carbohydrate metabolism in cancer cellsB Tan, S Dong, RL Shepard, L Kays, KD Roth, S Geeganage, MS Kuo, ...Journal of Biological Chemistry 290 (25), 15812-15824, 2015582015
5-) Nucleotides released from palmitate-activated murine macrophages attract neutrophilsTH Tam, KL Chan, P Boroumand, Z Liu, JT Brozinick, HH Bui, K Roth, ...Journal of Biological Chemistry 295 (15), 4902-4911, 2020322020